A patient with a history of chronic hepatitis C presents with jaundice, hepatomegaly, and signs of hepatic encephalopathy. After initiating treatment with lactulose, the patient remains lethargic and disoriented. Which nursing action is most appropriate to prioritize in this situation?

B) Reassess the patient's level of consciousness and perform a neurologic assessment.

A) Administer a diuretic to reduce abdominal distention.

B) Reassess the patient's level of consciousness and perform a neurologic assessment.

C) Encourage increased oral fluid intake to prevent dehydration.

D) Prepare the patient for an immediate liver biopsy to evaluate liver damage.

A patient with a history of chronic hepatitis C presents with worsening jaundice, mild abdominal distension, and cognitive changes suggestive of hepatic encephalopathy. After initiating lactulose therapy, the patient's mental status does not improve. Which of the following nursing interventions should be prioritized to further address the patient's condition?

C) Monitor serum ammonia levels and obtain a new set of liver function tests.

A) Increase the frequency of lactulose doses to enhance ammonia excretion.

B) Administer a high-protein diet to support liver regeneration.

C) Monitor serum ammonia levels and obtain a new set of liver function tests.

D) Prepare the patient for an emergency liver transplant evaluation.

A patient with worsening liver function exhibits signs of confusion, increased abdominal discomfort, and hypotension. After laboratory tests reveal elevated serum ammonia levels and a rise in liver enzymes, what is the most appropriate initial nursing intervention to support the patient's condition?

A) Administer lactulose to reduce serum ammonia levels

B) Increase oral fluid intake to manage hypotension

C) Provide high-protein diet to support liver function

D) Encourage ambulation to improve circulation

A patient with worsening liver function and suspected sepsis is experiencing hypotension, elevated liver enzymes, and increased serum ammonia levels. Which nursing intervention is the priority to address the patient's current hemodynamic instability?

B) Initiating intravenous fluids to counteract hypotension.

A) Administering lactulose to reduce serum ammonia levels.

B) Initiating intravenous fluids to counteract hypotension.

C) Administering acetaminophen to manage the low-grade fever.

D) Preparing the patient for a liver biopsy to assess hepatic injury.

A patient with a diagnosis of spontaneous bacterial peritonitis (SBP) is receiving cefotaxime and albumin infusion. Which assessment finding should the nurse prioritize to report to the healthcare provider?

C) Increased confusion and disorientation

D) Bradycardia with a heart rate of 60 beats per minute

A patient with liver cirrhosis presents with ascites, jaundice, hypotension, and suspected spontaneous bacterial peritonitis (SBP). After a diagnostic paracentesis shows a high serum-ascites albumin gradient and elevated white cell count, the clinical team initiates treatment. Which of the following is the most critical nursing intervention to prioritize after starting intravenous antibiotics and albumin infusion?

B) Assess neurological status frequently for changes in mental state.

A) Monitor for signs of allergic reactions to the antibiotics.

B) Assess neurological status frequently for changes in mental state.

C) Measure abdominal girth to monitor ascites progression.

D) Encourage oral fluid intake to prevent dehydration.

A patient with advanced liver disease is showing signs of potential hepatorenal syndrome. The clinical team is considering adding terlipressin to the treatment regimen. What primary nursing consideration should be prioritized when administering terlipressin to this patient?

B) Assess for peripheral vasoconstriction and hypertension.

A) Monitor for signs of improved hepatic function.

B) Assess for peripheral vasoconstriction and hypertension.

C) Evaluate the patient for potential allergic reactions.

D) Ensure adequate hydration to avoid further renal impairment.

A patient with advanced liver disease and ascites is being treated for suspected hepatorenal syndrome. Which of the following nursing interventions is most appropriate to prioritize in this scenario?

B) Monitor urine output and report any significant decrease immediately.

A) Encourage increased oral fluid intake to support renal function.

B) Monitor urine output and report any significant decrease immediately.

C) Administer diuretics as ordered to reduce fluid overload.

D) Position the patient in a Trendelenburg position to enhance renal perfusion.

A patient with worsening hepatic encephalopathy and signs of hepatorenal syndrome is being managed in a hospital setting. The nursing team is preparing to administer terlipressin as recommended by the nephrology team. Which nursing intervention is most critical to implement before initiating this medication?

B) Assess the patient's baseline blood pressure and heart rate.

A) Monitor the patient's serum potassium levels.

B) Assess the patient's baseline blood pressure and heart rate.

C) Review the patient's liver function test results.

D) Evaluate the patient's recent intake and output records.

A patient with hepatic encephalopathy is being treated with lactulose and rifaximin. The nurse notices the patient is now more lethargic and disoriented, with asterixis present. The lab results indicate a serum sodium level of 129 mEq/L and a climbing creatinine level. Which nursing intervention should be prioritized to address these clinical findings?

C) Prepare for the administration of terlipressin as ordered by nephrology.

A) Increase the frequency of lactulose administration to promote bowel movements.

B) Restrict fluid intake to correct the hyponatremia.

C) Prepare for the administration of terlipressin as ordered by nephrology.

D) Initiate a low-protein diet to reduce ammonia production.

hyperbilirubinemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Excessive bilirubin production occurs when there is increased breakdown of red blood cells, as seen in hemolytic anemias, leading to an overwhelming bilirubin load for the liver to process.

• Secondary mechanism: Impaired hepatic uptake or conjugation of bilirubin can result from liver dysfunction, such as in hepatitis or cirrhosis, where the liver's ability to convert bilirubin into its water-soluble form is compromised.

• Key complication: Accumulation of unconjugated bilirubin can lead to jaundice and, if severe, may result in bilirubin encephalopathy or kernicterus, particularly in neonates, emphasizing the need for prompt diagnosis and management.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Chronic hepatitis C, history of gallstones

• Current medications: Ursodeoxycholic acid, ribavirin, multivitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Yellowing of the skin and eyes, fatigue

• Key symptoms: Jaundice, dark urine, pale stools, abdominal pain, nausea

• Vital signs: Blood pressure 140/90 mmHg, heart rate 105 bpm, respiratory rate 18 breaths per minute, temperature 37.5°C

Section 1

As the clinical team proceeds with the initial assessment, they note that the patient's jaundice has intensified, with the sclera appearing more icteric. The patient's abdomen is mildly distended, and there is tenderness upon palpation, particularly in the right upper quadrant. A thorough examination reveals hepatomegaly, suggesting liver involvement, possibly due to progression of his chronic hepatitis C or complications from gallstones. The patient reports a significant increase in fatigue over the past few days, and his partner mentions that he has been more forgetful and occasionally disoriented, raising concerns about hepatic encephalopathy.

Routine laboratory tests are ordered to assess the severity of the hyperbilirubinemia and potential liver dysfunction. The results show elevated total bilirubin levels at 5.6 mg/dL, with a predominant increase in unconjugated bilirubin. Liver function tests reveal an increase in alanine aminotransferase (ALT) at 98 U/L and aspartate aminotransferase (AST) at 110 U/L, indicative of hepatic injury. Alkaline phosphatase is slightly elevated at 150 U/L. An ultrasound of the abdomen is performed, which shows evidence of gallbladder sludge but no obvious biliary obstruction. These findings suggest that the patient's jaundice is primarily due to liver dysfunction rather than an obstructive process.

The clinical team decides to initiate treatment targeting potential hepatic encephalopathy, prescribing lactulose to help reduce the ammonia levels contributing to the patient's mental status changes. Despite these interventions, the patient remains lethargic and his disorientation persists, prompting the team to consider further diagnostic evaluations and possible escalation of care. This situation underscores the need for close monitoring and reevaluation of treatment effectiveness, as well as consideration of additional complications that may arise, such as worsening liver function or further deterioration in mental status.

Section 2

Despite the initial interventions, the patient's condition begins to show concerning signs of deterioration. Over the next 48 hours, the patient experiences increased abdominal discomfort, and his jaundice becomes more pronounced. His mental status fluctuates significantly, with periods of confusion alternating with somnolence. The clinical team observes that the patient's vital signs are becoming unstable, with blood pressure dropping to 98/62 mmHg and heart rate increasing to 112 beats per minute. These changes raise alarms about the possibility of worsening liver function or an emerging systemic complication such as sepsis. The patient's temperature is slightly elevated at 100.4°F, further suggesting an infectious process or inflammatory response.

In light of these developments, additional laboratory tests are ordered to reassess liver function and detect any evolving complications. The results reveal a marked increase in total bilirubin to 7.2 mg/dL, now with a rise in conjugated bilirubin, indicating mixed hyperbilirubinemia. The liver enzymes continue to trend upward, with ALT at 130 U/L and AST at 140 U/L, suggesting ongoing hepatic injury. Prothrombin time has also increased to 18 seconds, and serum ammonia levels are elevated at 85 µmol/L, highlighting a worsening hepatic function. Blood cultures are drawn to rule out infectious etiology given the low-grade fever and hypotension.

The clinical team decides to broaden the patient's management plan, initiating empirical antibiotic therapy to address potential sepsis and considering the need for further aggressive interventions such as albumin infusion or transfer to a higher level of care for closer monitoring. This juncture requires the team to carefully evaluate the effectiveness of current treatments and anticipate the need for more intensive support, recognizing the delicate balance between managing complications and optimizing the patient's overall stability. Decisions will need to be made about the potential for liver transplantation evaluation or other advanced therapies, depending on the patient's response to the current management strategy.

Section 3

In response to the concerning signs of deterioration, the clinical team carefully monitors the patient for any changes in status. Over the next 24 hours, the patient's mental state continues to fluctuate, with episodes of agitation and disorientation becoming more frequent. His abdominal pain intensifies, and he reports a sensation of fullness that raises suspicion of ascites. A focused physical examination reveals shifting dullness on percussion of the abdomen, confirming the presence of ascitic fluid. Simultaneously, his jaundice becomes even more pronounced, with scleral icterus clearly visible. Vital signs indicate a further decline in hemodynamic stability, with blood pressure dropping to 92/58 mmHg and heart rate increasing to 118 beats per minute. Oxygen saturation is slightly decreased at 94% on room air, and respiratory rate has increased to 24 breaths per minute, suggesting a compensatory response to hypoperfusion or metabolic acidosis.

Given these findings, the team decides to perform a diagnostic paracentesis to analyze the ascitic fluid, aiming to identify the underlying cause of the fluid accumulation. The ascitic fluid analysis reveals a high serum-ascites albumin gradient (SAAG), consistent with portal hypertension, and an elevated white cell count, raising suspicion for spontaneous bacterial peritonitis (SBP). The potential for SBP, coupled with the patient's low-grade fever and hypotension, strengthens the case for an infectious process contributing to his clinical decline.

With the new diagnostic results indicating possible SBP, the clinical team modifies the treatment plan to include targeted intravenous antibiotics, such as cefotaxime, to address the suspected bacterial infection. Additionally, they initiate albumin infusion to support intravascular volume and counteract the effects of hypotension. The patient's response to these interventions will be closely monitored, with particular attention to changes in mental status, vital signs, and laboratory markers. The team remains vigilant, prepared to escalate care if necessary, including considering consultation with a transplant center for evaluation of liver transplantation, should the patient's condition fail to stabilize with current measures.

Section 4

As the clinical team implements the modified treatment plan, the patient's condition is closely monitored for any signs of improvement or further deterioration. Within the next 12 hours, the patient's vital signs show a mixed response to the interventions. His blood pressure remains borderline at 94/60 mmHg; however, his heart rate has decreased slightly to 110 beats per minute, suggesting a modest response to the volume expansion provided by the albumin infusion. Oxygen saturation has stabilized at 95% on room air, but his respiratory rate remains elevated at 22 breaths per minute, indicating ongoing compensatory mechanisms.

Laboratory results reveal a mixed picture. Liver function tests show a slight improvement, with total bilirubin decreasing from 18 mg/dL to 16 mg/dL, and hepatic enzymes slightly reduced, hinting at a potential response to the antibiotic therapy. However, the patient's renal function is becoming a concern, with creatinine levels rising from 1.2 mg/dL to 1.6 mg/dL, suggesting the onset of hepatorenal syndrome, a known complication in patients with advanced liver disease and ascites. This development prompts the clinical team to initiate discussions regarding nephrology consultation and consider adding vasoconstrictors like terlipressin to the treatment regimen to support renal perfusion.

Despite these complications, the patient exhibits brief periods of lucidity, suggesting intermittent improvement in hepatic encephalopathy symptoms. However, his fluctuating mental status and persistent abdominal discomfort necessitate continued vigilance. The team acknowledges the need for a potential escalation of care if further deterioration occurs, including more aggressive interventions or early transfer to a higher level of care, such as a liver transplant center. As the patient's journey progresses, the clinical team remains poised to adapt their approach based on his evolving clinical status and any new complications that may arise.

Section 5

As the clinical team continues to monitor the patient, they observe a notable change in his status. Approximately eight hours after the last evaluation, the patient begins to exhibit signs of worsening hepatic encephalopathy. He becomes increasingly lethargic and disoriented, failing to respond appropriately to simple commands. This altered mental status prompts the team to perform a thorough neurological assessment, revealing asterixis, a classic sign of hepatic encephalopathy. The team is concerned about the progression and considers increasing the frequency of lactulose administration to help reduce ammonia levels further. In addition, rifaximin is added to the treatment regimen to target intestinal bacteria that produce ammonia, aiming to complement the effects of lactulose.

Concurrently, a repeat set of laboratory tests highlights additional concerns. Although total bilirubin continues to slowly decrease, now at 15 mg/dL, the patient's renal function is deteriorating further with creatinine climbing to 1.9 mg/dL. This trend solidifies the suspicion of hepatorenal syndrome. The nephrology team is consulted, and they recommend initiating a continuous infusion of terlipressin to enhance renal perfusion and improve kidney function. Additionally, the patient's electrolyte panel reveals hyponatremia, with serum sodium dropping to 129 mEq/L, likely secondary to fluid shifts and dilutional effects from the patient's ascites and ongoing volume management. This necessitates careful correction to prevent further neurological impairment.

The evolving clinical scenario prompts the team to re-evaluate the patient's care plan. They discuss the potential need for more intensive monitoring in a step-up unit, where he can receive closer surveillance and rapid intervention should his condition deteriorate further. The clinical team communicates with the patient’s family about the current challenges and the possibility of transferring him to a specialized liver transplant center if his liver function does not stabilize. Meanwhile, the team remains vigilant in adjusting the management strategy, balancing the risks of aggressive intervention against the potential benefits, as they strive to stabilize the patient and prevent further complications.